BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30408153)

  • 21. Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma.
    Watanabe J; Natsumeda M; Kanemaru Y; Okada M; Oishi M; Kakita A; Fujii Y
    Leuk Lymphoma; 2019 Dec; 60(14):3587-3589. PubMed ID: 31305194
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.
    Yamada S; Ishida Y; Matsuno A; Yamazaki K
    Leuk Lymphoma; 2015 Jul; 56(7):2141-5. PubMed ID: 25347427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
    Boire A; Brandsma D; Brastianos PK; Le Rhun E; Ahluwalia M; Junck L; Glantz M; Groves MD; Lee EQ; Lin N; Raizer J; Rudà R; Weller M; Van den Bent MJ; Vogelbaum MA; Chang S; Wen PY; Soffietti R
    Neuro Oncol; 2019 May; 21(5):571-584. PubMed ID: 30668804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation.
    Carreno E; Clench T; Steeples LR; Salvatore S; Lee RWJ; Dick AD; Pawade J
    Acta Ophthalmol; 2019 Feb; 97(1):e138-e139. PubMed ID: 30113125
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
    Nayak L; Bettegowda C; Scherer F; Galldiks N; Ahluwalia M; Baraniskin A; von Baumgarten L; Bromberg JEC; Ferreri AJM; Grommes C; Hoang-Xuan K; Kühn J; Rubenstein JL; Rudà R; Weller M; Chang SM; van den Bent MJ; Wen PY; Soffietti R
    Neuro Oncol; 2024 Jun; 26(6):993-1011. PubMed ID: 38598668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYD88 (L265P) Mutation in Malignant Lymphoma Using Formalin-Fixed Paraffin-Embedded Section.
    Ogura G; Kikuti YY; Kikuchi T; Carreras J; Sato T; Nakamura N
    J Clin Exp Hematop; 2013; 53(2):175-7. PubMed ID: 23995116
    [No Abstract]   [Full Text] [Related]  

  • 28. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.
    Bravetti C; Degaud M; Armand M; Sourdeau E; Mokhtari K; Maloum K; Osman J; Verrier P; Houillier C; Roos-Weil D; Soussain C; Choquet S; Hoang-Xuan K; Le Garff-Tavernier M; Denis JA; Davi F
    Br J Haematol; 2023 Jun; 201(6):1088-1096. PubMed ID: 36941788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly sensitive
    Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
    Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
    Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
    Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature.
    Natsumeda M; Shibuma S; Takahashi H; On J; Mouri Y; Tomikawa K; Fujiwara H; Watanabe J; Tsukamoto Y; Okada M; Takeda R; Shimizu H; Takizawa J; Kakita A; Oishi M
    Brain Tumor Pathol; 2024 Apr; 41(2):85-91. PubMed ID: 38597999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis.
    Takano S; Hattori K; Ishikawa E; Narita Y; Iwadate Y; Yamaguchi F; Nagane M; Akimoto J; Oka H; Tanaka S; Sakata M; Matsuda M; Yamamoto T; Chiba S; Matsumura A
    World Neurosurg; 2018 Apr; 112():e69-e73. PubMed ID: 29258950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of the
    Zorofchian S; Lu G; Zhu JJ; Duose DY; Windham J; Esquenazi Y; Ballester LY
    Front Oncol; 2018; 8():382. PubMed ID: 30294590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of
    Takahashi H; Natsumeda M; On J; Watanabe J; Tada M; Shimizu H; Tsukamoto Y; Okada M; Oishi M; Takizawa J; Hayashi Y; Masaki Y; Kakita A; Fujii Y
    Leuk Lymphoma; 2023 Jun; 64(6):1219-1222. PubMed ID: 37070573
    [No Abstract]   [Full Text] [Related]  

  • 38. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes.
    Zhou Y; Liu W; Xu Z; Zhu H; Xiao D; Su W; Zeng R; Feng Y; Duan Y; Zhou J; Zhong M
    Neoplasia; 2018 Oct; 20(10):1059-1069. PubMed ID: 30227305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.
    Tan WJ; Wang MM; Ricciardi-Castagnoli P; Tang T; Chee SP; Lim TS; Chan ASY
    Blood; 2019 Aug; 134(8):709-712. PubMed ID: 31292111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.